Team:UCSF/Parts
From 2010.igem.org
(Difference between revisions)
Line 68: | Line 68: | ||
<body> | <body> | ||
<!-- add device list below --> | <!-- add device list below --> | ||
+ | |||
+ | <p>During the summer we built the following devices under the BioBrick standard <a href="https://2009.igem.org/Judging/Variance/UCSF">RFC28</a> (see more info <a href="http://dspace.mit.edu/bitstream/handle/1721.1/46721/BBFRFC28.pdf">here</a>), which was developed by the UCSF team in 2009 and was approved by the Registry of Parts. However, this year the Registry does not accept RFC28. Due to time constrains, we could not move all of these parts into pSB1C3 and submit them as we had planned.</p> | ||
<table id="customers"> | <table id="customers"> | ||
Line 81: | Line 83: | ||
</tr> | </tr> | ||
- | <tr> | + | <tr class="alt"> |
<td>John</td> | <td>John</td> | ||
<td>antiCD19CAR-DAP10-STOP</td> | <td>antiCD19CAR-DAP10-STOP</td> | ||
<td>Positive Control</td> | <td>Positive Control</td> | ||
</tr> | </tr> | ||
- | |||
<tr> | <tr> | ||
<td>Hannah</td> | <td>Hannah</td> | ||
Line 93: | Line 94: | ||
</tr> | </tr> | ||
- | <tr> | + | <tr class="alt"> |
<td>Lianna</td> | <td>Lianna</td> | ||
<td>antiCD19CAR-mDAP10N87Q-STOP</td> | <td>antiCD19CAR-mDAP10N87Q-STOP</td> | ||
<td>Negative Control</td> | <td>Negative Control</td> | ||
</tr> | </tr> | ||
- | |||
<tr> | <tr> | ||
<td>Sam</td> | <td>Sam</td> | ||
Line 105: | Line 105: | ||
</tr> | </tr> | ||
- | <tr> | + | <tr class="alt"> |
<td>Crystal</td> | <td>Crystal</td> | ||
<td>antiMESOCAR-DAP10-CD3Z</td> | <td>antiMESOCAR-DAP10-CD3Z</td> | ||
<td>Stronger Signaling</td> | <td>Stronger Signaling</td> | ||
</tr> | </tr> | ||
- | |||
<tr> | <tr> | ||
<td>Crystal</td> | <td>Crystal</td> | ||
Line 117: | Line 116: | ||
</tr> | </tr> | ||
- | <tr> | + | <tr class="alt"> |
<td>Crystal</td> | <td>Crystal</td> | ||
<td>antiMESOCAR-DAP10-DAP10</td> | <td>antiMESOCAR-DAP10-DAP10</td> | ||
<td>Stronger Signaling</td> | <td>Stronger Signaling</td> | ||
</tr> | </tr> | ||
- | |||
<tr> | <tr> | ||
<td>Sam</td> | <td>Sam</td> | ||
Line 129: | Line 127: | ||
</tr> | </tr> | ||
- | <tr> | + | <tr class="alt"> |
<td>Sam</td> | <td>Sam</td> | ||
<td>antiCD19CAR-DAP10-Dap10</td> | <td>antiCD19CAR-DAP10-Dap10</td> | ||
Line 161: | Line 159: | ||
<tr> | <tr> | ||
<td>Crystal</td> | <td>Crystal</td> | ||
- | <td>antiMESOCAR -LFA1 -DAP10</td> | + | <td>antiMESOCAR-LFA1-DAP10</td> |
<td>Stronger Signaling</td> | <td>Stronger Signaling</td> | ||
</tr> | </tr> | ||
Line 183: | Line 181: | ||
<td>antiMESOCAR-OX40-CD3z</td> | <td>antiMESOCAR-OX40-CD3z</td> | ||
<td>Stronger Signaling</td> | <td>Stronger Signaling</td> | ||
- | |||
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 200: | Line 197: | ||
<td>Stronger Signaling</td> | <td>Stronger Signaling</td> | ||
</tr> | </tr> | ||
- | |||
<tr> | <tr> | ||
<td>Carmen</td> | <td>Carmen</td> | ||
Line 245: | Line 241: | ||
<td>antiCD19CAR-OX40-CD3z</td> | <td>antiCD19CAR-OX40-CD3z</td> | ||
<td>Stronger Signaling</td> | <td>Stronger Signaling</td> | ||
- | |||
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 252: | Line 247: | ||
<td>Stronger Signaling</td> | <td>Stronger Signaling</td> | ||
</tr> | </tr> | ||
- | |||
<tr> | <tr> | ||
<td>Carmen</td> | <td>Carmen</td> | ||
Line 288: | Line 282: | ||
<td>Stronger Signaling</td> | <td>Stronger Signaling</td> | ||
</tr> | </tr> | ||
- | |||
<tr> | <tr> | ||
<td>Lianna</td> | <td>Lianna</td> | ||
Line 324: | Line 317: | ||
<td>Stronger Signaling</td> | <td>Stronger Signaling</td> | ||
</tr> | </tr> | ||
- | |||
<tr> | <tr> | ||
<td>Crystal</td> | <td>Crystal</td> | ||
Line 360: | Line 352: | ||
<td>Stronger Signaling</td> | <td>Stronger Signaling</td> | ||
</tr> | </tr> | ||
- | |||
<tr> | <tr> | ||
<td>Crystal</td> | <td>Crystal</td> |
Revision as of 23:11, 27 October 2010
Parts
<groupparts>iGEM010 UCSF</groupparts>
During the summer we built the following devices under the BioBrick standard RFC28 (see more info here), which was developed by the UCSF team in 2009 and was approved by the Registry of Parts. However, this year the Registry does not accept RFC28. Due to time constrains, we could not move all of these parts into pSB1C3 and submit them as we had planned.
Designed by | Ligated parts | Function |
Carmen | Old antiMesoCAR-LFA1-Dap10 | Stronger Signaling |
John | antiCD19CAR-DAP10-STOP | Positive Control |
Hannah | antiCD19CAR-mDAP10y85F-STOP | Stronger Signaling |
Lianna | antiCD19CAR-mDAP10N87Q-STOP | Negative Control |
Sam | antiMESOCAR-mDAP10N87Q-STOP | Logic Gate Signaling |
Crystal | antiMESOCAR-DAP10-CD3Z | Stronger Signaling |
Crystal | antiMESOCAR- LFA1-CD3z | Stronger Signaling |
Crystal | antiMESOCAR-DAP10-DAP10 | Stronger Signaling |
Sam | antiCD19CAR-DAP10-CD3z | Stronger Signaling |
Sam | antiCD19CAR-DAP10-Dap10 | Stronger Signaling |
Sam | antiCD19CAR-CD3z-CD3z | Stronger Signaling |
Carmen | antiMESOCAR-CD3Z-STOP | Positive Control |
Carmen | antiCD19-CD3z-STOP | Stronger Signaling |
Carmen | antiMESOCAR-KIR3DL2-STOP | Inhibition |
Carmen | antiCD19CAR-KIR3DL2-STOP | Inhibition |
Crystal | antiMESOCAR-LFA1-DAP10 | Stronger Signaling |
Crystal | antiMESOCAR-mDAP10 M88Q-STOP | Logic Gate Signaling |
Crystal | antiCD19CAR-mDAP10 M88Q-STOP | Logic Gate Signaling |
Lianna | antiMESOCAR-OX40-Dap10 | Stronger Signaling |
Lianna | antiMESOCAR-OX40-CD3z | Stronger Signaling |
Carmen | antiMESOCAR-FcRg-DAP10 | Stronger Signaling |
Carmen | antiMESOCAR-ICOS-DAP10 | Stronger Signaling |
Carmen | antiCD19CAR-FcRg-DAP10 | Stronger Signaling |
Carmen | antiCD19CAR-ICOS-DAP10 | Stronger Signaling |
Carmen | antiCD19CAR-LFA1-DAP10 | Stronger Signaling |
Crystal | antiMESOCAR-CD3z-CD3z | Stronger Signaling |
Lianna | antiMESOCAR-mDAP10Y85F-STOP | Logic Gate Negative Control |
Connor | antiCD19CAR-KIR3DL1-STOP | Inhibition |
Connor | antiMESOCAR-KIR3DL1-STOP | Inhibition |
Crystal | antiMESOCAR-DAP10-STOP | Stronger Signaling |
Lianna | antiCD19CAR-OX40-DAP10 | Stronger Signaling |
Lianna | antiCD19CAR-OX40-CD3z | Stronger Signaling |
Carmen | antiCD19CAR-SLAMF1-CD3z | Stronger Signaling |
Carmen | antiCD19CAR-SLAMF1-DAP10 | Stronger Signaling |
Carmen | antiCD19CAR-SLAMF5-DAP10 | Stronger Signaling |
John | antiMESOCAR-SLAMF1-CD3z | Stronger Signaling |
John | antiMESOCAR-SLAMF5-DAP10 | Stronger Signaling |
Lianna | antiCD19CAR-FcRg-STOP | Stronger Signaling |
Lianna | antiCD19CAR-ICOS-STOP | Stronger Signaling |
Lianna | antiCD19CAR-CD28-STOP | Stronger Signaling |
Lianna | antiMESOCAR-FcRg-STOP | Stronger Signaling |
Lianna | antiMESOCAR-ICOS-STOP | Stronger Signaling |
Lianna | antiMESOCAR-CD28-STOP | Stronger Signaling |
Lianna | antiCD19CAR-LFA1-STOP | Stronger Signaling |
Lianna | antiMESOCAR-LFA1-STOP | Stronger Signaling |
Crystal | antiCD19CAR-LFA1-CD3z | Stronger Signaling |
Crystal | antiMESOCAR-OX40-STOP | Stronger Signaling |
Crystal | antiMESOCAR-SLAMF3-CD3z | Stronger Signaling |
Crystal | antiMESOCAR- CD3g-CD3z | Stronger Signaling |
Crystal | antiMESOCAR-Ly49-STOP | Stronger Signaling |
Crystal | antiMESOCAR-NKG2A-STOP | Negative Feedback |
Crystal | antiCD19CAR-OX40-STOP | Stronger Signaling |
Crystal | antiCD19CAR-SLAMF3-CD3z | Stronger Signaling |
Crystal | antiCD19CAR-CD3g-CD3z | Stronger Signaling |
Crystal | antiCD19CAR-FcRg-CD3z | Stronger Signaling |
Min | GZMB-eGFP-CDMPR | Localization to Cytoxic Granules |
Min | GZMB-eGFP-GILT | Localization to Cytoxic Granules |
Min | GZMB-eGFP-LAMP | Localization to Cytoxic Granules |
Min | GZMB-eGFP-LIMP | Localization to Cytoxic Granules |
Min | GZMB-eGFP-Ymotif | Localization to Cytoxic Granules |
Min | GZMB-eGFP-STP | Localization to Cytoxic Granules |
Min | GZMM-eGFP-CDMPR | Localization to Cytoxic Granules |
Min | GZMM-eGFP-GILT | Localization to Cytoxic Granules |
Min | GZMM-eGFP-LAMP | Localization to Cytoxic Granules |
Min | GZMM-eGFP-LIMP | Localization to Cytoxic Granules |
Min | GZMM-eGFP-Ymotif | Localization to Cytoxic Granules |
Min | GZMM-eGFP-STP | Localization to Cytoxic Granules |